Home
Browse
Search
Statistics
About
Usage
PMID: 9559222
De Braekeleer M, Allard C, Leblanc JP, Aubin G, Simard F
Correlation of sweat chloride concentration with genotypes in cystic fibrosis patients in Saguenay Lac-Saint-Jean, Quebec, Canada.
Clin Biochem. 1998 Feb;31(1):33-6.,
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
3
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:3:34
status:
NEW
view ABCC7 p.Ala455Glu details
Results: CF patients carrying the
A455E
mutation, usually associated with pancreatic sufficiency, had lower sweat chloride concentrations than those carrying mutations associated with pancreatic insufficiency (⌬F508 and 621ϩ1G3T).
Login to comment
25
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:25:113
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:25:126
status:
NEW
view ABCC7 p.Ala455Glu details
Three CFTR mutations account for 93.7% of the CF chromosomes; these are the ⌬F508 (63.4%), 621ϩ1G3T
(22.3
%), and
A455E
(8%) mutations.
Login to comment
28
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:28:87
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:28:118
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:28:125
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:28:161
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:28:174
status:
NEW
view ABCC7 p.Ala455Glu details
All the 114 CF patients in the present study had pancreatic insufficiency but 7 with a
A455E
/⌬F508 genotype, 2
with
a
A455E
/621ϩ1G3T genotype and 1
with
a R177C/
A455E
genotype who were pancreatic sufficient.
Login to comment
38
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:38:18
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:38:60
status:
NEW
view ABCC7 p.Ala455Glu details
Patients with the
A455E
/⌬F508 or the 621ϩ1G3T/
A455E
genotype had significantly lower chloride values than those homozygous for the ⌬F508 mutation (p Ͻ 0.05).
Login to comment
39
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:39:18
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:39:47
status:
NEW
view ABCC7 p.Ala455Glu details
Patients with the
A455E
/DF508 or the 62111G3T/
A455E
genotype had significantly lower chloride values than those homozygous for the DF508 mutation (p , 0.05).
Login to comment
40
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:40:73
status:
NEW
view ABCC7 p.Ala455Glu details
A significant difference was also found between CF patients carrying the
A455E
mutation on one chromosome and the ⌬F508 or 621ϩ1G3T mutation on the other chromosome (p Ͻ 0.05).
Login to comment
41
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:41:73
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 9559222:41:206
status:
NEW
view ABCC7 p.Tyr1092* details
There were no significant differences in sweat chloride values between pa
tient
s homozygous for the ⌬F508 mutation and those having a ⌬F508/ 621ϩ1G3T genotype or being hemizygous for the
Y1092X
or 711ϩ1G3T mutation (p Ͼ 0.05).
Login to comment
42
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 9559222:42:186
status:
NEW
view ABCC7 p.Tyr1092* details
There were no significant differences in sweat chloride values between patients homozygous for the DF508 mutation and those having a DF508/ 62111G3T genotype or being hemizygous for the
Y1092X
or 71111G3T mutation (p .
Login to comment
44
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:44:57
status:
NEW
view ABCC7 p.Ala455Glu details
It was the result of significant differences between the
A455E
group and the other two groups, ⌬F508 and 621ϩ1G3T (p Ͻ 0.05).
Login to comment
45
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:45:135
status:
NEW
view ABCC7 p.Ala455Glu details
Patients were classified as hemizygous for the ⌬F508 mutation if the other chromosome did not carry the 621ϩ1G3T, nor the
A455E
mutation.
Login to comment
46
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:46:22
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:46:57
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:46:76
status:
NEW
view ABCC7 p.Ala455Glu details
Patients carrying the
A455E
mutation on one chromosome we
re in
cluded in the
A455E
mutation category, independently of the second mutation.
Login to comment
47
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:47:122
status:
NEW
view ABCC7 p.Ala455Glu details
Patients were classified as hemizygous for the DF508 mutation if the other chromosome did not carry the 62111G3T, nor the
A455E
mutation.
Login to comment
48
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:48:22
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:48:76
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:48:355
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:48:384
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:48:868
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 9559222:48:427
status:
NEW
view ABCC7 p.Tyr1092* details
Pancreatic insufficien
cy (P
I) is obtained TABLE 1 Sweat Chloride Concentrati
ons b
y Genotype or Mutation Among CF Patients in SLSJ Genotype No. of Patients Mean Chloride Concentration (mEq/L) (SD) Minimum Value (mEq/L) Maximum Value (mEq/L) ⌬F508/⌬F508 47 102.77 (8.43) 77 119 621ϩ1G3T/⌬F508 28 103.5 (7.4) 87 120 621ϩ1G3T/
A455E
6 94.17 (10.87) 74 106
A455E
/⌬F508 12 77.08 (18.48) 54 107
Y1092X
/⌬F508 or 621ϩ1G3T 5 100.6 (11.67) 87 117 621ϩ1G3T/621ϩ1G3T 5 112.4 (2.97) 108 116 621ϩ1G3T/711ϩ1G3T 4 106.5 (4.12) 102 110 ⌬F508/other 3 102.33 (11.5) 91 114 Other/other 2 71 62 80 621-other 2 89.5 84 95 Mutation No. of Patients Mean Chloride Concentration (mEq/L) (SD) Minimum Value (mEq/L) Maximum Value (mEq/L) ⌬F508 54 102.28 (8.56) 77 119 621ϩ1G3T 40 104.55 (8.14) 84 120
A455E
19 81.68 (18.14) 54 107 when a CF patient has two 'severe` alleles with respect to the exocrine pancreatic function (⌬F508 being one of them).
Login to comment
50
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:50:322
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:50:351
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:50:771
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 9559222:50:387
status:
NEW
view ABCC7 p.Tyr1092* details
Pancreatic insufficiency (PI) is obtained TABLE 1 Sweat Chloride Concentrations by Genotype or Mutation Among CF Patients in SLSJ Genotype No. of Patients Mean Chloride Concentration (mEq/L) (SD) Minimum Value (mEq/L) Maximum Value (mEq/L) DF508/DF508 47 102.77 (8.43) 77 119 62111G3T/DF508 28 103.5 (7.4) 87 120 62111G3T/
A455E
6 94.17 (10.87) 74 106
A455E
/DF508 12 77.08 (18.48) 54 107
Y1092X
/DF508 or 62111G3T 5 100.6 (11.67) 87 117 62111G3T/62111G3T 5 112.4 (2.97) 108 116 62111G3T/71111G3T 4 106.5 (4.12) 102 110 DF508/other 3 102.33 (11.5) 91 114 Other/other 2 71 62 80 621-other 2 89.5 84 95 Mutation No. of Patients Mean Chloride Concentration (mEq/L) (SD) Minimum Value (mEq/L) Maximum Value (mEq/L) DF508 54 102.28 (8.56) 77 119 62111G3T 40 104.55 (8.14) 84 120
A455E
19 81.68 (18.14) 54 107 when a CF patient has two 'severe` alleles with respect to the exocrine pancreatic function (DF508 being one of them).
Login to comment
51
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:51:60
status:
NEW
view ABCC7 p.Ala455Glu details
However, the follow-up of CF patients with one mild allele (
A455E
) has shown that some PS patients may develop pancreatic insufficiency at a later stage of the disease (14).
Login to comment
53
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:53:60
status:
NEW
view ABCC7 p.Ala455Glu details
However, the follow-up of CF patients with one mild allele (
A455E
) has shown that some PS patients may develop pancreatic insufficiency at a later stage of the disease (14).
Login to comment
55
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 9559222:55:49
status:
NEW
view ABCC7 p.Tyr1092* details
In class I, there is no protein synthesis (e.g.,
Y1092X
, 621ϩ1G3T, 711ϩ1G3T mutations).
Login to comment
57
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9559222:57:104
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9559222:57:111
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9559222:57:119
status:
NEW
view ABCC7 p.Gly85Glu details
ABCC7 p.Tyr1092*
X
ABCC7 p.Tyr1092* 9559222:57:49
status:
NEW
view ABCC7 p.Tyr1092* details
In class III, the CFTR protein reaches the cell m
embran
e but is irresponsive to cAMP stimulation (e.g.,
G551D
,
N1303K
,
G85E
mutations).
Login to comment
58
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9559222:58:82
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:58:220
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 9559222:58:89
status:
NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 9559222:58:96
status:
NEW
view ABCC7 p.Ser1251Asn details
Class IV mutations result in a reduction in the amount of chloride current (e.g.,
R117H
,
R347P
,
S1251N
mutations) while class V mutations result in a reduction in the amount of a normally functioning CFTR protein (e.g.,
A455E
, 3849ϩ10kbC3T mutations).
Login to comment
59
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9559222:59:104
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9559222:59:111
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly85Glu
X
ABCC7 p.Gly85Glu 9559222:59:119
status:
NEW
view ABCC7 p.Gly85Glu details
In class III, the CFTR protein reaches the cell membrane but is irresponsive to cAMP stimulation (e.g.,
G551D
,
N1303K
,
G85E
mutations).
Login to comment
60
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9559222:60:82
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:60:220
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 9559222:60:89
status:
NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Ser1251Asn
X
ABCC7 p.Ser1251Asn 9559222:60:96
status:
NEW
view ABCC7 p.Ser1251Asn details
Class IV mutations result in a reduction in the amount of chloride current (e.g.,
R117H
,
R347P
,
S1251N
mutations) while class V mutations result in a reduction in the amount of a normally functioning CFTR protein (e.g.,
A455E
, 3849110kbC3T mutations).
Login to comment
65
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:65:86
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:65:112
status:
NEW
view ABCC7 p.Ala455Glu details
It was the case for ⌬F508/⌬F508 versus 621ϩ1G3T/621ϩ1G3T or
A455E
/⌬F508 versus
A455E
/621ϩ1G3T.
Login to comment
67
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:67:60
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:67:79
status:
NEW
view ABCC7 p.Ala455Glu details
It was the case for DF508/DF508 versus 62111G3T/62111G3T or
A455E
/DF508 versus
A455E
/62111G3T.
Login to comment
69
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9559222:69:906
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9559222:69:490
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:69:1132
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:69:1165
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9559222:69:365
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9559222:69:836
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9559222:69:843
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9559222:69:868
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9559222:69:290
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 9559222:69:709
status:
NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 9559222:69:673
status:
NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9559222:69:327
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9559222:69:252
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 9559222:69:943
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 9559222:69:950
status:
NEW
view ABCC7 p.Arg1162* details
Simone Aubin, Claudette La- rochelle and Suzanne Mignault from the Clinique de TABLE 2 Distribution of the Mean Sweat Chloride Concentration by Genotype Genotype No. of CF Patients Mean Chloride Concentration (mmol/L) (SD) Pancreatic Status References
G542X
/⌬F508 128 109 (23) Pl 18
R553X
/⌬F508 46 105 (18) Pl 18
N1303K
/⌬F508 56 104 (24) Pl 18
W1282X
/⌬F508 13 110 (18) Pl 18 1717-1G3A/⌬F508 26 107 (36) Pl 18 621ϩ1G3T/⌬F508 22 100 (20) Pl 18
R117H
/⌬F508 20 82 (19) PS 18 ⌬F508/⌬F508 328 106 (22) Pl 18 3849ϩ10kb C3T/⌬F508 6 61 (11) PS 19 3849ϩ10kb C3T/⌬F508 9 41 (12) PS (6) 20
R347P
/⌬F508 5 100 (26) Pl 21
R334W
/⌬F508 10 108 (19) Pl (6) 22 1811ϩ1.6kb A3C/⌬F508a 17 98 (12) Pl 23 3905insT/⌬F508 7 124 Pl 24
W1282X
/
W1282X
16 113 (12) Pl 25
W1282X
/⌬F508 22 109 (11) Pl 25
G551D
/⌬F508 58 101 (16) Pl 26
R1162X
/
R1162X
9 99 (13) Pl 27 1949del84/⌬F508 4 105 (20) Pl 28 ⌬F508/⌬F508 47 103 (8) Pl This study 621ϩ1G3T/⌬F508 28 103 (7) Pl This study 621ϩ1G3T/
A455E
6 94 (11) Pl/PS This study
A455E
/⌬F508 12 77 (18) Pl/PS This study a Or other 'severe` mutations.
Login to comment
71
ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 9559222:71:768
status:
NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Arg117His
X
ABCC7 p.Arg117His 9559222:71:440
status:
NEW
view ABCC7 p.Arg117His details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:71:947
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Ala455Glu
X
ABCC7 p.Ala455Glu 9559222:71:980
status:
NEW
view ABCC7 p.Ala455Glu details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9559222:71:342
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9559222:71:705
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9559222:71:712
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 9559222:71:737
status:
NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 9559222:71:281
status:
NEW
view ABCC7 p.Arg553* details
ABCC7 p.Arg334Trp
X
ABCC7 p.Arg334Trp 9559222:71:605
status:
NEW
view ABCC7 p.Arg334Trp details
ABCC7 p.Arg347Pro
X
ABCC7 p.Arg347Pro 9559222:71:576
status:
NEW
view ABCC7 p.Arg347Pro details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 9559222:71:311
status:
NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 9559222:71:250
status:
NEW
view ABCC7 p.Gly542* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 9559222:71:798
status:
NEW
view ABCC7 p.Arg1162* details
ABCC7 p.Arg1162*
X
ABCC7 p.Arg1162* 9559222:71:805
status:
NEW
view ABCC7 p.Arg1162* details
Simone Aubin, Claudette Larochelle and Suzanne Mignault from the Clinique de TABLE 2 Distribution of the Mean Sweat Chloride Concentration by Genotype Genotype No. of CF Patients Mean Chloride Concentration (mmol/L) (SD) Pancreatic Status References
G542X
/DF508 128 109 (23) Pl 18
R553X
/DF508 46 105 (18) Pl 18
N1303K
/DF508 56 104 (24) Pl 18
W1282X
/DF508 13 110 (18) Pl 18 1717-1G3A/DF508 26 107 (36) Pl 18 62111G3T/DF508 22 100 (20) Pl 18
R117H
/DF508 20 82 (19) PS 18 DF508/DF508 328 106 (22) Pl 18 3849110kb C3T/DF508 6 61 (11) PS 19 3849110kb C3T/DF508 9 41 (12) PS (6) 20
R347P
/DF508 5 100 (26) Pl 21
R334W
/DF508 10 108 (19) Pl (6) 22 181111.6kb A3C/DF508a 17 98 (12) Pl 23 3905insT/DF508 7 124 Pl 24
W1282X
/
W1282X
16 113 (12) Pl 25
W1282X
/DF508 22 109 (11) Pl 25
G551D
/DF508 58 101 (16) Pl 26
R1162X
/
R1162X
9 99 (13) Pl 27 1949del84/DF508 4 105 (20) Pl 28 DF508/DF508 47 103 (8) Pl This study 62111G3T/DF508 28 103 (7) Pl This study 62111G3T/
A455E
6 94 (11) Pl/PS This study
A455E
/DF508 12 77 (18) Pl/PS This study a Or other 'severe` mutations.
Login to comment